Amarogentin Inhibits Liver Cancer Cell Angiogenesis after Insufficient Radiofrequency Ablation via Affecting Stemness and the p53-Dependent VEGFA/Dll4/Notch1 Pathway

BACKGROUND: Whether and how amarogentin suppresses the angiogenesis effect in liver cancer cells after insufficient radiofrequency ablation (iRFA) are still poorly studied. METHODS: The number of liver cancer stem cells (LCSCs) and the level of vascular endothelial growth factor A (VEGFA) were asses...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yongchuan, Zhang, Yinglin, Wang, Jin, Gu, Haitao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7596460/
https://www.ncbi.nlm.nih.gov/pubmed/33145353
http://dx.doi.org/10.1155/2020/5391058

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7596460/
https://www.ncbi.nlm.nih.gov/pubmed/33145353
http://dx.doi.org/10.1155/2020/5391058

Ejemplares similares